PIRIDOXAMINE FOR USE IN THE TREATMENT OF DIABETIC NEPHROPATHY IN TYPE II DIABETES.

摘要

Use of pyridoxamine, or a pharmaceutically acceptable salt thereof, for the preparation of a pharmaceutical composition for treating diabetic nephropathy in a human patient with type II diabetes with a baseline serum creatinine concentration greater than or equal to 1.3 mg / dl.